Evidence map›Paper›PMID 25500891›Full record

ArticleMolecular medicine reports2015

Identification of histamine receptor subtypes in skeletal myogenesis.

Yan Chen, Vasily Stegaev, Vesa-Petteri Kouri, Tarvo Sillat, Paul L Chazot, Holger Stark, Jian Guo Wen, Yrjö T Konttinen

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Histamine HFrontiers in pharmacology · 2021
    Article
  3. A New Edible Film to Produce In Vitro Meat.Foods (Basel, Switzerland) · 2020
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Yan ChenDepartment of Medicine, Institute of Clinical Medicine, University of Helsinki, Biomedicum 1, Helsinki 00029, Finland.
Vasily StegaevDepartment of Medicine, Institute of Clinical Medicine, University of Helsinki, Biomedicum 1, Helsinki 00029, Finland.
Vesa-Petteri KouriDepartment of Medicine, Institute of Clinical Medicine, University of Helsinki, Biomedicum 1, Helsinki 00029, Finland.
Tarvo SillatDepartment of Medicine, Institute of Clinical Medicine, University of Helsinki, Biomedicum 1, Helsinki 00029, Finland.
Paul L ChazotSchool of Biological and Biomedical Sciences, Durham University, Durham DH1 3LE, UK.
Holger StarkInstitute of Pharmaceutical Chemistry, Goethe University, Frankfurt D‑60438, Germany.
Jian Guo WenDepartment of Urology, Pediatric Urodynamic Center, Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
Yrjö T KonttinenDepartment of Medicine, Institute of Clinical Medicine, University of Helsinki, Biomedicum 1, Helsinki 00029, Finland.
University of Helsinki · FIDurham University · GBFirst Affiliated Hospital of Zhengzhou University · CNGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, conventional and/or novel histamine receptors (HRs) have not been investigated in mouse skeletal myogenesis. Therefore, the present study aimed to investigate the HR‑subtypes in skeletal myogenesis. The myogenesis of C2C12 skeletal myoblasts was evaluated using desmin, myogenin and myosin heavy chain (Myh) as early, intermediate and late differentiation markers, respectively. Reverse transcription‑quantitative polymerase chain reaction and immunostaining were performed and the messenger RNA (mRNA) expression levels of the HR‑subtypes and markers were determined. H1R mRNA was found to be highly expressed in myoblasts at day 0; however, the expression levels were reduced as differentiation progressed. By contrast, H2R mRNA expression remained constant, while H3R mRNA expression increased by 28‑, 103‑ and 198‑fold at days 2, 4 and 6 compared with the baseline level (day 0), respectively. In addition, Myh expression increased by 7,718‑, 94,487‑ and 286,288‑fold on days 2, 4 and 6 compared with the baseline expression level (day 0). Weak positive staining of the cells for H3R protein was observed on day 2, whereas highly positive staining was observed on days 4 and 6. HR expression during myogenesis was, in part, regulated by the stage of differentiation. These results along with previous findings indicated possible involvement of H1R in the regulation of progenitor cell mitogenesis and of H2R in the relaxation of acetylcholine‑stimulated contraction of muscle cells, following the activation of professional histamine‑producing cells, including mast cells. By contrast, H3R may participate in the regulation of specialized myocyte functions, potentially by maintaining the relaxed state under the influence of constitutive H3R activity and low histamine concentrations, locally produced/released by non‑professional histamine‑producing cells.

Indexed as

AnimalsCell LineGene ExpressionImmunohistochemistryMiceMuscle DevelopmentMuscle, SkeletalReceptors, HistamineRNA, MessengerReceptors, HistamineRNA, Messenger

Identifiers

PMID25500891
PMCPMC4337477
OpenAlexW1999405653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.